Alvotech wins UK case over production of Regeneron protected eye medicine
Icelandic biotechnology company Alvotech did not need to identify the planned country of sale before invoking a patent protection waiver to produce a version of Regeneron's eye medicine aflibercept, a UK judge has...To view the full article, register now.
Already a subscriber? Click here to view full article